Cargando…
Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition
BACKGROUND: Polycystic ovary syndrome (PCOS), characterized by androgen excess and ovulatory dysfunction, is associated with a high prevalence of obesity and insulin resistance (IR) in women. We demonstrated that sodium–glucose cotransporter-2 inhibitor (SGLT2i) administration decreases fat mass wit...
Autores principales: | Pruett, Jacob E., Everman, Steven J., Hoang, Ngoc H., Salau, Faridah, Taylor, Lucy C., Edwards, Kristin S., Hosler, Jonathan P., Huffman, Alexandra M., Romero, Damian G., Yanes Cardozo, Licy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389812/ https://www.ncbi.nlm.nih.gov/pubmed/35986388 http://dx.doi.org/10.1186/s13293-022-00455-x |
Ejemplares similares
-
OR35-01 Colonic Mitochondrial Dysfunction and Sub-acute Gastrointestinal Inflammation in Two Hyperandrogenemic Rodent Models of PCOS
por: Hoang, Ngoc, et al.
Publicado: (2023) -
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021) -
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
por: Huffman, Alexandra M., et al.
Publicado: (2021) -
Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
por: Pruett, Jacob E, et al.
Publicado: (2021) -
Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors
por: Pruett, Jacob E., et al.
Publicado: (2023)